• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Bioluminescence Ventures debuts with $477M to speed up drug discovery

cafead

Administrator
Staff member
  • cafead   Nov 01, 2023 at 10:32: AM
via Bioluminescence Ventures, a San Francisco-based life sciences venture capital firm, made its official debut on Wednesday with a $350 million first fund aimed at faster development of experimental drugs

article source